E. Miles Vaughan Williams

E. Miles Vaughan Williams's AcademicInfluence.com Rankings

Medical

#2050

World Rank

#2444

Historical Rank

Pharmacology

#211

World Rank

#251

Historical Rank

medical Degrees

Download Badge

Medical

E. Miles Vaughan Williams's Degrees

Bachelors Biology University of Oxford

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is E. Miles Vaughan Williams Influential?

(Suggest an Edit or Addition)

(See a Problem?)

E. Miles Vaughan Williams's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A Classification of Antiarrhythmic Actions Reassessed After a Decade of New Drugs (1984) (587)
The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle (1970) (555)
A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474 (1970) (388)
Small‐nerve junctional potentials. The distribution of small motor nerves to frog skeletal muscle, and the membrane characteristics of the fibres they innervate * (1953) (333)
Properties of the ‘slow’ skeletal muscle fibres of the frog * (1953) (293)
THE EFFECTS ON CARDIAC MUSCLE OF β‐RECEPTOR ANTAGONISTS IN RELATION TO THEIR ACTIVITY AS LOCAL ANAESTHETICS (1965) (248)
The effect of altered thyroid state on atrial intracellular potentials (1970) (213)
Effect of Altering Potassium Concentration on the Action of Lidocaine and Diphenylhydantoin on Rabbit Atrial and Ventricular Muscle (1971) (198)
Mode of action of beta receptor antagonists on cardiac muscle. (1966) (126)
The effects of acetylcholine in the heart‐lung preparation including the production of auricular fibrillation (1955) (100)
EFFECTS ON RABBIT NODAL, ATRIAL, VENTRICULAR AND PURKINJE CELL POTENTIALS OF A NEW ANTIARRHYTHMIC DRUG, CIBENZOLINE, WHICH PROTECTS AGAINST ACTION POTENTIAL SHORTENING IN HYPOXIA (1982) (92)
Investigations of the mode of action of a new antidysrhythmic drug, Kö 1173 (1972) (90)
The relevance of β‐receptor blockade to ouabain‐induced cardiac arrhythmias (1969) (89)
The mode of action of quinidine on isolated rabbit atria interpreted from intracellular potential records. (1958) (88)
Prevention of arrhythmias due to cardiac glycosides by block of sympathetic beta receptors. (1963) (84)
A comparison of the anti‐arrhythmic actions of I.C.I. 50172 and (—)‐propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function (1969) (78)
Characterization of a new oral antiarrhythmic drug, flecainide (R818) (1981) (76)
The effects of prolonged beta-adrenoceptor blockade on heart weight and cardiac intracellular potentials in rabbits. (1975) (71)
Subgroups of class 1 antiarrhythmic drugs. (1984) (65)
The individual effects of CO2, bicarbonate and pH on the electrical and mechanical activity of isolated rabbit auricles (1955) (61)
Classifying Antiarrhythmic Actions: By Facts or Speculation (1992) (59)
A comparison of tests for antifibrillatory action. (1961) (58)
Classification of Antiarrhythmic Actions (1989) (57)
Local Anæsthetic Activity of the β-Receptor Antagonist, Pronethalol (1964) (56)
Cardiospecificity of -receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular -adrenoceptors of propranolol, of practolol and its ortho-substituted isomer, and of oxprenolol and its para-substituted isomer. (1973) (56)
Pacemaker selectivity: influence on rabbit atria of ionic environment and of alinidine, a possible anion antagonist. (1981) (54)
Chemosensitivity of cardiac muscle (1967) (53)
Histamine Release and Intracellular Potentials During Anaphylaxis in the Isolated Heart (1960) (51)
Loss of cellular potassium as a cause of intestinal paralysis in dogs (1952) (51)
Significance of Classifying Antiarrhythmic Actions Since the Cardiac Arrhythmia Suppression Trial (1991) (49)
Antifibrillatory action (1962) (47)
Some observations concerning the mode of action of acetylcholine in isolated rabbit atria (1958) (47)
Electrophysiological effects of α‐adrenoceptor antagonists in rabbit sino‐atrial node, cardiac Purkinje cells and papillary muscles (1984) (44)
The effect of bretylium on intracellular cardiac action potentials in relation to its anti‐arrhythmic and local anaesthetic activity (1969) (44)
INVESTIGATIONS TO CHARACTERIZE A NEW ANTI‐ARRHYTHMIC DRUG, ORG 6001, INCLUDING A SIMPLE TEST FOR CALCIUM ANTAGONISM (1976) (43)
Adaptation of hypertensives to treatment with cardioselective and non-selective beta-blockers. Absence of correlation between bradycardia and blood pressure control, and reduction in slope of the QT/RR relation. (1980) (42)
Pacemaker potentials. The excitation of isolated rabbit auricles by acetylcholine at low temperatures (1956) (40)
THE MODE OF ACTION OF DRUGS UPON INTESTINAL MOTILITY (1954) (38)
Local anaesthetic and anti‐arrhythmic actions of alprenolol relative to its effect on intracellular potentials and other properties of isolated cardiac muscle (1970) (37)
Effects on cardiac muscle of the β‐adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve (1971) (34)
The effect of changes in extracellular potassium concentration on the intracellular potentials of isolated rabbit atria (1959) (32)
QT and action potential duration. (1982) (31)
MORPHOMETRIC CHANGES IN RABBIT VENTRICULAR MYOCARDIUM PRODUCED BY LONG-TERM BETA-ADRENOCEPTOR BLOCKADE (1977) (28)
The effect of prolonged propranolol administration on myocardial transmural capillary density in young rabbits. (1981) (27)
Delayed ventricular repolarization as an anti-arrhythmic principle. (1985) (25)
The experimental basis for the choice of an anti-arrhythmic drug. (1970) (24)
The effects of various fatty acids on action potential shortening during sequential periods of ischaemia and reperfusion. (1980) (24)
The formation of acetylcholine in the heart; its effect on the systemic output and its importance for auricular fibrillation caused by aconitine (1956) (23)
Intracellular Na and K concentrations of rabbit atria, in relation to the action of quinidine (1962) (22)
Electrophysiological and Cardiovascular Effects of Pirmenol, a New Class 1 Antiarrhythmic Drug (1986) (21)
Electrophysiological basis for a rational approach to antidysrhythmic drug therapy. (1974) (21)
A study of intracellular potentials and contractions in atria, including evidence for an after‐potential (1959) (20)
ANION ANTAGONISM—A FIFTH CLASS OF ANTIARRHYTHMIC ACTION? (1981) (20)
DIFFERENTIAL ACTIONS ON RABBIT NODAL, ATRIAL, PURKINJE CELL AND VENTRICULAR POTENTIALS OF MELPERONE, A BRADYCARDIC AGENT DELAYING REPOLARIZATION: EFFECTS OF HYPOXIA (1982) (20)
Cardiovascular effects of bevantolol, a selective β1‐adrenoceptor antagonist with a novel pharmacological profile (1985) (19)
Effect of prolonged beta-receptor blockade on dry weight and electrophysiological responses of rabbit hearts. (1974) (18)
LOCAL ANAESTHETIC ACTIVITY OF THE BETA-RECEPTOR ANTAGONIST, PRONETHALOL. (1964) (18)
The Effects of Indecainide, a New Antidysrhythmic Drug, on Nodal Tissues in the Isolated Rabbit Heart (1986) (18)
Effects on rabbit cardiac potentials of aprindine and indecainide, a new antiarrhythmic agent, in normoxia and hypoxia (1985) (17)
ADAPTATIONAL RESPONSES TO PROLONGED β‐ADRENOCEPTOR BLOCKADE IN ADULT RABBITS (1980) (17)
THE PRODUCTION OF BLOCK AND AURICULAR FIBRILLATION IN THE HEART-LUNG PREPARATION BY INHIBITORS OF CHOLINESTERASE (1955) (17)
Relevance of cellular to clinical electrophysiology in interpreting antiarrhythmic drug action (1989) (16)
ELECTROPHYSIOLOGICAL AND OTHER EFFECTS ON RABBIT HEARTS OF CCI 22277, A NEW STEROIDAL ANTIARRHYTHMIC DRUG (1982) (16)
The influence of intraluminal pressure upon the transport of fluid through cannulated Thiry‐Vella loops in dogs (1951) (16)
EFFECT OF PROLONGED β‐ADRENOCEPTOR BLOCKADE ON HEART WEIGHT AND ULTRASTRUCTURE IN YOUNG RABBITS (1980) (15)
The development of sensitivity to acetylcholine in denervated muscle (1949) (15)
Inhibition and neuromuscular paralysis in Ascaris lumbricoides (1963) (15)
The relevance of cellular to clinical electrophysiology in classifying antiarrhythmic actions. (1992) (14)
The absence of effect of chemical sympathectomy on ventricular hypertrophy induced by hypoxia in young rabbits. (1983) (12)
Effect of bicarbonate administration on skeletal muscle intracellular pH in the rat: implications for acute administration of bicarbonate in man. (1992) (12)
Classification of the Antiarrhythmic Action of Moricizine (1991) (11)
CENTRAL AND PERIPHERAL ACTIONS OF PRONETHALOL (1965) (11)
Bevantolol: A Beta‐1 Adrenoceptor Antagonist with Unique Additional Actions (1987) (10)
Relation of Extracellular to Intracellular Potential Records from Single Cardiac Muscle Fibres (1959) (10)
Further studies regarding the structure activity relationships of β‐adrenoceptor antagonists (1973) (10)
Simultaneous measurements of contractions and intracellular potentials in isolated rabbit atria exposed to acetylcholine (1959) (9)
A SIMPLIFIED INTEGRATING LIGHT RECORDER FOR FIELD USE. (1943) (9)
CENTRAL NERVOUS SYSTEM EFFECTS OF BETA ADRENERGIC BLOCKING DRUGS (1967) (9)
The effect on intracellular atrial potentials of bretylium in relation to its local anaesthetic potency. (1969) (8)
The effect of prolonged treatment with oxyfedrine on intracellular potentials and on other features of cardiac function in rabbits and guinea‐pigs (1973) (8)
The effects of nadolol on various cardiac tissues in normoxia, and on atrial muscle in simulated ischaemia. (1982) (7)
Na+/H+ and HCO3-/Cl- exchange in the control of intracellular pH in vivo in the spontaneously hypertensive rat. (1991) (6)
Long-term effects of propranolol on tyrosine hydroxylase and dopamine-beta-hydroxylase in the superior cervical ganglia of the rabbit [proceedings]. (1976) (6)
Further studies of alinidine induced bradycardia in the presence of caesium. (1986) (6)
AN INEXPENSIVE INTEGRATING LIGHT RECORDER. (1941) (5)
The action of posterior pituitary extracts upon propulsion in the small intestine of conscious dogs. (1952) (5)
Is Phosphodiesterase Inhibition Arrhythmogenic? Electrophysiologic Effects in Pithed Rats and in Normoxic and Hypoxic Rabbit Atria of Enoximone, a New Cardiotonic Agent (1987) (5)
Antiarrhythmic action of specific bradycardic agents (1987) (5)
The action of quinidine interpreted from intracellular potentials of single cardiac fibres. (1958) (5)
The effects on cardiac muscle and nerve of a fluorinated decahydroquinoline derivative, L7810, rapidly absorbed after oral administration (1973) (5)
The effect on atrial and ventricular intracellular potentials, and other pharmacological actions of L9146, a non-halogenated benzo(b)thiophene related to amiodarone. (1977) (4)
THE ACTION OF PRONETHALOL ON SPINAL REFLEXES (1965) (4)
Urea excretion by rabbits (1946) (3)
Control of Cardiac Rhythm (1998) (3)
The development of new antidysrhythmic drugs. (1973) (3)
Relief of postoperative pain and intestinal motility. (1950) (3)
The mode of action of morphine upon the intestine. (1951) (3)
A-V Block and Cardiac Output (1955) (2)
The Action of Beta-Receptor Blocking Agents on Cardiac Muscle (1967) (2)
Electrophysiological aspects of the action of antiarrhythmic drugs. (1969) (2)
Disopyramide (1984) (1)
The measurement of secretion and absorption by intestinal loops in conscious dogs. (1951) (1)
Hypoxia‐induced cardiac hypertrophy in rabbits treated with verapamil and nifedipine (1983) (1)
Calcium Currents Mediating Inotropic and Chronotropic Effects in Mammalian Cardiac Muscle (1980) (1)
A vertical approach to cardiac arrhythmias (1986) (1)
Adrenergic arrhythmogenicity. (1988) (1)
Cellular basis of cardiac dysrhythmias. (1974) (0)
Electrophysiological and other effects on cardiac function of KO 1173. (1973) (0)
Antiarrhythmic Drug Development: Classification and its Impact on Development. (1995) (0)
Effect of analgesics and of electrolyte changes on intestinal motility. (1956) (0)
Adaptation ofhypertensives totreatmentwith cardioselective andnon-selective beta-blockers Absence ofcorrelation between bradycardia and (1980) (0)
THE ACTION OF MORPHINE, PETHIDINE, AND AMIDONE UPON THE INTESTINAL MOTILITY OF CONSCIOUS DOGS (2006) (0)
Proceedings of the physiological society [proceedings]. (1977) (0)
[Importance of experimental studies on anti-arrhythmia agents and their clinical use]. (1978) (0)
RABBIT ATRIA INTERPRETED FROM INTRACELLULAR POTENTIAL RECORDS (2006) (0)
[Advances in the knowledge of new anti-dysrhythmic drugs]. (1973) (0)
The Scientific Basis for the Use of Drugs in Cardiovascular Disease (1969) (0)
Proceedings: Possible explanation for protective action of long-term beta-adrenoceptor blockade after myocardial infarction. (1976) (0)
Studies on the mode of action of cardioactive drugs in animals and man (1982) (0)
Emotional Expressions in ttention-Deficit / Hyperactivity Disorder : Evidence or a Neural Marker and Stimulant Effects (2008) (0)
[beta receptors. Contrast between the acute and prolonged effects of beta blockers]. (1978) (0)
Cardiac Electrophysiological Effects of Selective Adrenoceptor Stimulation and Their Possible Roles in Arrhythmias (1985) (0)
35 Mode of action of antifibrillatory drugs (1961) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With E. Miles Vaughan Williams?

E. Miles Vaughan Williams is affiliated with the following schools:

University of Oxford

E. Miles Vaughan Williams's Academic­Influence.com Rankings